{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:55:22Z","timestamp":1762005322027,"version":"3.41.2"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cardiac involvement in Anderson\u2013Fabry disease (AFD) can lead to arrhythmia, including ventricular tachycardia (VT). The literature on radiofrequency ablation (RFA) for the treatment of VT in AFD disease is limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case summary<\/jats:title><jats:p>We discuss RFA of drug-refractory VT electrical storm in three males with AFD. The first patient (53\u2009years old) had extensive involvement of the inferolateral left ventricle (LV) demonstrated with cardiac magnetic resonance imaging (CMRI), with a left ventricular ejection fraction (LVEF) of 35%. Two VT ablation procedures were performed. At the first procedure, the inferobasal endocardial LV was ablated. Furthermore, VT prompted a second ablation, where epicardial and endocardial sites were ablated. The acute arrhythmia burden was controlled but he died 4 months later despite appropriate implantable cardioverter-defibrillator therapies for VT. The second patient (67\u2009years old) had full-thickness inferolateral involvement demonstrated with CMRI and LVEF of 45%. RFA of several endocardial left ventricular sites was performed. Over a 3-year follow-up, only brief non-sustained VT was identified, but he subsequently died of cardiac failure. Our third patient (69\u2009years old), had an LVEF of 35%. He had RFA of endocardial left ventricular apical disease, but died 3 weeks later of cardiac failure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>RFA of drug-refractory VT in AFD is feasible using standard electrophysiological mapping and ablation techniques, although the added clinical benefit is of questionable value. VT storm in the context of AFD may be a marker of end-stage disease.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ehjcr\/ytaa529","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T11:00:53Z","timestamp":1612782053000},"source":"Crossref","is-referenced-by-count":3,"title":["Radiofrequency ablation of ventricular tachycardia in Anderson\u2013Fabry disease: a case series"],"prefix":"10.1093","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5425-7739","authenticated-orcid":false,"given":"Mark T","family":"Mills","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Northern General Hospital, Herries Road, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Northern General Hospital, Herries Road, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas F","family":"Kelland","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Northern General Hospital, Herries Road, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Sahu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Northern General Hospital, Herries Road, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2444-0169","authenticated-orcid":false,"given":"Justin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Northern General Hospital, Herries Road, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Northern General Hospital, Herries Road, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarekegn","family":"Hiwot","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital Birmingham, Mindelsohn Way, Birmingham, B15 2TH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas L","family":"Kyriacou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Northern General Hospital, Herries Road, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"key":"2021020407401950200_ytaa529-B1","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.2174\/13816128113199990353","article-title":"Fabry disease and cardiovascular involvement","volume":"19","author":"Anastasakis","year":"2013","journal-title":"Curr Pharm Des"},{"key":"2021020407401950200_ytaa529-B2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/eurheartj\/ehi143","article-title":"The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease","volume":"26","author":"Weidemann","year":"2005","journal-title":"Eur Heart J"},{"key":"2021020407401950200_ytaa529-B3","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/clc.22047","article-title":"Arrhythmias in Fabry cardiomyopathy","volume":"35","author":"Acharya","year":"2012","journal-title":"Clin Cardiol"},{"key":"2021020407401950200_ytaa529-B4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.amjcard.2016.04.033","article-title":"Usefulness of an implantable loop recorder to detect clinically relevant arrhythmias in patients with advanced fabry cardiomyopathy","volume":"118","author":"Weidemann","year":"2016","journal-title":"Am J Cardiol"},{"key":"2021020407401950200_ytaa529-B5","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.amjcard.2014.06.019","article-title":"Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease","volume":"114","author":"Kr\u00e4mer","year":"2014","journal-title":"Am J Cardiol"},{"key":"2021020407401950200_ytaa529-B6","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1540-8159.2005.00241.x","article-title":"Ventricular tachycardias and dilated cardiomy-opathy caused by Fabry disease","volume":"28","author":"Igawa","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"key":"2021020407401950200_ytaa529-B7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jjcc.2008.10.004","article-title":"Dilated phase of hypertrophic cardiomyopathy caused by Fabry disease with atrial flutter and ventricular tachycardia","volume":"54","author":"Fukuzawa","year":"2009","journal-title":"J Cardiol"},{"key":"2021020407401950200_ytaa529-B8","doi-asserted-by":"crossref","first-page":"f153","DOI":"10.1093\/europace\/eux261","article-title":"Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice","volume":"20","author":"Baig","year":"2018","journal-title":"Europace"},{"key":"2021020407401950200_ytaa529-B9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.hrthm.2010.08.006","article-title":"Endocardial and epicardial substrates of ventricular tachycardia in a patient with Fabry disease","volume":"8","author":"Higashi","year":"2011","journal-title":"Heart Rhythm"},{"key":"2021020407401950200_ytaa529-B10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1880-4276(10)80009-2","article-title":"Catheter ablation of reentrant left ventricular tachycardia associated with Fabry disease: a case report","volume":"26","author":"Nakano","year":"2010","journal-title":"J Arrhythm"},{"key":"2021020407401950200_ytaa529-B11","first-page":"187","article-title":"Ventricular tachycardia substrate voltage map and radiofrequency ablation in a patient with Fabry\u2019s disease cardiomyopathy","volume":"2","author":"Ellis","year":"2011","journal-title":"J Innov Card Rhythm Manag"},{"key":"2021020407401950200_ytaa529-B12","doi-asserted-by":"crossref","first-page":"A12895","DOI":"10.1161\/circ.134.suppl_1.12895","article-title":"Abstract 12895: Characteristics and outcome of ventricular tachycardia in advanced Fabry disease cardiomyopathy","volume":"134","author":"Oder","year":"2016","journal-title":"Circulation"},{"key":"2021020407401950200_ytaa529-B13","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1136\/heartjnl-2019-315229","article-title":"Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy","volume":"105","author":"Vijapurapu","year":"2019","journal-title":"Heart"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcr\/article-pdf\/5\/2\/ytaa529\/36186595\/ytaa529.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcr\/article-pdf\/5\/2\/ytaa529\/36186595\/ytaa529.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T20:05:47Z","timestamp":1724443547000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytaa529\/6127622"}},"subtitle":[],"editor":[{"given":"Borislav","family":"Dinov","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Robert","family":"Sch\u00f6nbauer","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Goksel","family":"Cinier","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Max","family":"Sayers","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Vishal","family":"Shahil Mehta","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytaa529","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2021,2,1]]},"article-number":"ytaa529"}}